The Dallas Observer and reporter Amy Silverstein offer this coverage of the Martha Salazar v. Boston Scientific trial underway in Dallas. She wrote a May feature story, about the Batiste trial. She was awarded $1.2 million by a jury in her defective mesh case against Johnson & Johnson. Jurors also found her TVT-O was defectively designed.
The second trial, currently under way, is against Boston Scientific, over its Obtryx mesh, another polypropylene permanent device implanted in women with no FDA assurances for safety.
Here is Silverstein’s continuing coverage.